The risk of vancomycin toxicity in patients with liver impairment

BACKGROUND: The influence of liver disease on the pharmacokinetic profile, the risk of acute kidney injury, and excessive drug exposure in patients treated with vancomycin was examined. METHODS: A retrospective cohort study was performed with patients discharged from a medical center between January...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Microbiol Antimicrob
Egile Nagusiak: Brunetti, Luigi, Song, Jong Hwa, Suh, David, Kim, Heui Jae, Seong, Yeon Hee, Lee, Dae Song, Lee, Seung-Mi, Suh, Dong-Churl
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110653/
https://ncbi.nlm.nih.gov/pubmed/32234065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-020-00354-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak